Approval · Notice of Compliance 37667 · 2026
ACTIFEMME: Notice of Compliance 37667
Issued June 5, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37667
- Date
- June 5, 2026
- Company
- Orb Pharma- Division Of Odan Laboratories Ltd.Point Claire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement between two manufacturers
- Canadian reference product
- ACTIVELLE (Novo Nordisk Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACTIFEMME | 02568829 | Approved |
Medicinal ingredients
- NORETHINDRONE ACETATE 0.5 MG per TAB
- ESTRADIOL HEMIHYDRATE 1 MG per TAB